LIN28B Monoclonal Antibody
Product Specifications
Background
Acts as a suppressor of microRNA (miRNA) biogenesis by specifically binding the precursor let-7 (pre-let-7), a miRNA precursor. Acts by binding pre-let-7 and recruiting ZCCHC11/TUT4 uridylyltransferase, leading to the terminal uridylation of pre-let-7. Uridylated pre-let-7 miRNAs fail to be processed by Dicer and undergo degradation. Specifically recognizes the 5'-GGAG-3' motif in the terminal loop of pre-let-7. Also recognizes and binds non pre-let-7 pre-miRNAs that contain the 5'-GGAG-3' motif in the terminal loop, leading to their terminal uridylation and subsequent degradation. Mediates MYC-mediated let-7 repression. Isoform 1, when overexpressed, stimulates growth of the breast adenocarcinoma cell line MCF-7. Isoform 2 has no effect on cell growth.
Synonyms
Lin-28B; LN28B_HUMAN; CSDD 2; CSDD2; FLJ16517; Lin 28 homolog B (C. elegans) ; Lin 28.2; Lin-28B; Protein lin-28 homolog B.
Gene ID
389421
Swiss Prot
Q6ZN17
Cellular Locus
Cytoplasm, Nucleus
Host
Mouse
Cross Reactivity
Human
Target
LIN28B
Clonality
Monoclonal
Clone
K7L3
Conjugation
Unconjugated
Source
Recombinant human LIN28B.
Applications
WB
Concentration
0.5µg/µl
Dilution
WB (WB=1:500-2000)
Buffer
0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Gene ID URL
389421
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items